Back to Search
NOE SARAVIA, M.D.
M.D.
Neonatal-Perinatal Medicine Physician
NPI: 1912269101Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
067985(GA)
Neonatal-Perinatal Medicine PhysicianPrimary
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
54641(CT)282636(NY)
Research & Publications (20)
Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.
PMID 19569974·J Infect Dis·2009
7-preclinical
Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
PMID 18824610·Antimicrob Agents Chemother·2008
7-preclinical
Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima, Colombia.
PMID 18256429·Am J Trop Med Hyg·2008
7-preclinical
Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis.
PMID 17299719·J Infect Dis·2007
8-other
Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.
PMID 17230422·J Infect Dis·2007
4-observational
Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment.
PMID 16845635·J Infect Dis·2006
7-preclinical
Comparative immunohistological analysis of the Montenegro skin test reaction in asymptomatic infection and in acute and chronic cutaneous leishmaniasis.
PMID 17361840·Biomedica·2006
4-observational
[Leishmaniasis: a public health challenge that demands concerted effort and will (editorial)].
PMID 17361835·Biomedica·2006
8-other
Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis.
PMID 16991092·J Infect Dis·2006
7-preclinical
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
PMID 16619185·J Infect Dis·2006
7-preclinical
Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis.
PMID 16325936·Mol Biochem Parasitol·2006
4-observational
Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.
PMID 16216395·Vaccine·2006
7-preclinical
Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.
PMID 15620471·Vaccine·2005
7-preclinical
Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.
PMID 15855523·Antimicrob Agents Chemother·2005
7-preclinical
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
PMID 16539034·J Parasitol·2005
7-preclinical
Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction.
PMID 15827280·Am J Trop Med Hyg·2005
7-preclinical
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
PMID 15678803·Biomedica·2004
7-preclinical
Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
PMID 15562618·J Parasitol·2004
7-preclinical
Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.
PMID 14506011·Antimicrob Agents Chemother·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 41 E POST RD
WHITE PLAINS, NY 10601 - Phone
- (914) 681-1253
Quick Facts
- NPI
- 1912269101
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile